GBS (NYSE:GBS) Shares Down 1.9% – Should You Sell?

GBS Inc. (NYSE:GBS) shares fell 1.9% on Tuesday . The stock traded as low as $0.6406 and last traded at $0.6642. 104,771 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 955,325 shares. The stock had previously closed at $0.6768.

GBS Stock Down 1.9%

The stock has a market capitalization of $9.89 million, a P/E ratio of -1.19 and a beta of 1.32. The company has a fifty day simple moving average of $1.02 and a two-hundred day simple moving average of $1.41.

About GBS

GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.